ABO-Incompatible Liver Transplantation – A Review of the Historical Background and Results

References

• Samuelsson BE, Breimer ME. ABH antigens: some basic aspects. Transplant Proc 1987;19(6):4401–4407.
   PubMed Web of Science ®Google Scholar
• Rouger PH, Poupon R, Gane P, et al. Expression of blood group antigens including HLA markers in human adult liver. Tissue Antigens 2008;27(2):78–86. doi:10.1111/j.1399-0039.1986.tb01502.x.
   Google Scholar
• Watkins WM. The ABO blood group system: historical background. Transfus Med 2001;11(4):243–265. doi:10.1046/j.1365-3148.2001.00321.x.
   PubMed Web of Science ®Google Scholar
• Montgomery RA, Cozzi E, West LJ, et al. Humoral immunity and antibody-mediated rejection in solid organ transplantation. Semin Immunol 2011;23(4):224–234. doi:10.1016/j.smim.2011.08.021.
   PubMed Web of Science ®Google Scholar
• Starzl TE, Koep LJ, Halgrimson CG, et al. Fifteen years of clinical liver transplantation. Gastroenterology 1979;77(2):375–388.
   PubMed Web of Science ®Google Scholar
• Gordon RD, Iwatsuki S, Esquivel CO, et al. Liver transplantation across ABO blood groups. Surgery 1986;100(2):342–348.
   PubMed Web of Science ®Google Scholar
• Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet 1990;336(8714):519–523.
   PubMed Web of Science ®Google Scholar
• Reding R, Veyckemans F, De Ville de Goyet J, et al. ABO-incompatible orthotopic liver allografting in urgent indications. Surg Gynecol Obstet 1992;174(1):59–63.
   PubMedGoogle Scholar
• Farges O, Kalil AN, Samuel D, et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 1995;59(8):1124–1133.
   PubMed Web of Science ®Google Scholar
• Song GW, Lee SG, Hwang s, et al. ABO-incompatible adult living donor liver transplantation under the desensitization protocol with rituximab. Am J Transplant 2016;16(1):157–170. doi:10.1111/ajt.13444.
   PubMed Web of Science ®Google Scholar
• Lee C-F, Cheng C-H, Wang Y-C, et al. Adult living donor liver transplantation across ABO-incompatibility. Medicine 2015;94(42):1–7.
   Web of Science ®Google Scholar
• Genberg H, Kumlien G, Wennberg L, et al. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2011;26(7):2394–2400. doi:10.1093/ndt/gfr237.
   PubMed Web of Science ®Google Scholar
• Rydberg L, Bengtsson A, Samuelsson O, et al. In vitro assessment of a new ABO absorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005;17(11):666–672. doi:10.1007/s00147-004-0775-7.
   PubMed Web of Science ®Google Scholar
• Tydén G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantations without splenectomy, using antigen specific immunoadsorption and rituximab. Am J Transplant 2005;5:145–148. doi:10.1111/j.1600-6143.2004.00653.x.
   PubMed Web of Science ®Google Scholar
• Norden G, Briggs D, Cockwell P, et al. Blood group ABO incompatible live donor renal transplantation using carbohydrate based immunoadsorption and anti-CD20 antibody treatment. Xenotransplantation 2006;13(2):148–153. doi:10.1111/j.1399-3089.2006.00280.x.
   PubMed Web of Science ®Google Scholar
• Tanabe M, Shimazu M, Wakabayashi G, et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 2002;73(12):1959–1961.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Matsuno N, Iwamoto H, et al. Successful case of adult ABO-incompatible liver transplantation: beneficial effects of intrahepatic artery infusion therapy: a case report. Transplant Proc 2004;36(8):2269–2273.
   PubMed Web of Science ®Google Scholar
• Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008;47(1):143–152. doi:10.1002/hep.21928.
   PubMed Web of Science ®Google Scholar
• Egawa H, Teramukai S, Haga H, et al. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study. Am J Transplant 2014;14(1):102–114. doi:10.1111/ajt.12520.
   PubMed Web of Science ®Google Scholar
• Song GW, Lee SG, Hwang S, et al. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT. Transplantation 2014;97:59–66.
   Web of Science ®Google Scholar
• Sawada T, Fuchinoue S, Teraoka S, et al. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusion, splenectomy and double-filtration plasmapheresis. Transplantation 2002;74(9):1207–1210. doi:10.1097/00007890-200211150-00001.
   PubMed Web of Science ®Google Scholar
• Monteiro I, McLoughlin LM, Fisher A, et al. Rituximab with plasmapheresis and splenectomy in abo-incompatible liver transplantation. Transplantation 2003;76(11):1648–1649. doi:10.1097/01.TP.0000082723.02477.87.
   PubMed Web of Science ®Google Scholar
• Song GW, Lee SG, Hwang S, et al. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era. J Hepatol 2014;61(3):575–582. doi:10.1016/j.jhep.2014.04.039.
   PubMed Web of Science ®Google Scholar
• Plosker GL, Figgit DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003;63(8):803–843. doi:10.2165/00003495-200363080-00005.
   PubMed Web of Science ®Google Scholar
• Egawa H, Umeshita K, Uemoto S. Optimal dosage regimen for rituximab in ABO-incompatible living donor liver transplantation. J Hepatobiliary Pancreat Sci 2017;24(2):89–94. ():doi:10.1002/jhbp.419.
   PubMed Web of Science ®Google Scholar
• Raut V, Mori A, Kaido T, et al. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab. Transplantation 2012;93(1):99–105. doi:10.1097/TP.0b013e318239e8e4.
   PubMed Web of Science ®Google Scholar
• Jordan SC, Quartel AW, Czer LS, et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998;66(6):800–805.
   PubMed Web of Science ®Google Scholar
• Stanley C, Jordan MD, Ashley VO, et al. Desensitization therapy with intravenous gammaglobulin (IVIG): applications in solid organ transplantation. Trans Am Clin Climatol Assoc 2006;117:199–211.
   PubMedGoogle Scholar
• Montgomery RA, Loupy A, Segev DL. Antibody-mediated rejection: new approaches in prevention and management. Am J Transplant 2018;18(Special issue S3):3–7.
   PubMedGoogle Scholar
• Hanto DW, Fecteau AH, Alonso MH, et al. ABO-Incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy and quadruple immunosuppression: evidence for accommodation. Liver Transpl 2003;9(1):22–30. doi:10.1053/jlts.2003.50011.
   PubMed Web of Science ®Google Scholar
• Mendes M, Ferreira A, Ferreira F, et al. ABO-incompatible liver transplantation in acute liver failure: a single Portuguese center study. Transplant Proc 2013;45(3):1110–1115. doi:10.1016/j.transproceed.2013.02.012.
   PubMed Web of Science ®Google Scholar
• Shen T, Lin B-Y, Jia J-J, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. Hepatobiliary Pancreat Dis Int 2014; 13(4):395–400. doi:10.1016/S1499-3872(14)60268-X.
   PubMed Web of Science ®Google Scholar
• Genberg H, Hansson A, Wernerson A, et al. Pharmacodynamics of rituximab in kidney transplantation. Am J Transplant 2006;6(10):2418–2428.
   PubMed Web of Science ®Google Scholar
• Thorsen T, Dahlgren US, Aandahl EM, et al. Liver transplantation with deceased donors is life-saving but associated with increased risk of rejection and post-transplant complications. Transpl Int 2015;28(7):800–812. doi:10.1111/tri.12552.
   PubMed Web of Science ®Google Scholar
• Economidou J, Hugh-Jones N, Gardner B. Quantitative measurements concerning A and B antigen sites. Vox Sanguinis 1967;12(5):321–328. doi:10.1111/j.1423-0410.1967.tb03362.x.
   PubMed Web of Science ®Google Scholar
• Visetti M, Leigheb G. Scudeller, Ceppellini Importanza dei sottogruppi A1-A2 e delle reazioni crociati A-B per la sopravvienza di alloinnesti di cute. Minerva Dermatol. 1967;42:563–569.
   PubMedGoogle Scholar
• Ceppellinin R, Bigliani S, Curtoni, et al. Experimental allotransplantation in man. The role of A1, A2 and B antigens; III. Enhancement by circulation antibody. Transplant Proc 1969;1:390–394.
   PubMed Web of Science ®Google Scholar
• Rydberg L, Breimer ME, Samuelsson BE, et al. Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: a clinical, serologic and biochemical approach. Transplant Proc 1987;19:4528.
   PubMed Web of Science ®Google Scholar
• Fishbein T, Emre S, Guy S, et al. Safe transplantation of blood type A2 livers to blood type O recipients. Transplantation 1999;67(7):1071–1073.
   PubMed Web of Science ®Google Scholar
• Skogsberg U, Breimer ME, Friman S, et al. Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc 2006;38(8):2667–2670. doi:10.1016/j.transproceed.2006.07.025.
   PubMed Web of Science ®Google Scholar
• Kluger MD, Guarrera JV, Olsen SK, et al. Safety of blood group A2-to-O liver transplantation: an analysis of the united network of organ sharing database. Transplantation 2012;94(5):526–531. doi:10.1097/TP.0b013e31825c591e.
   PubMed Web of Science ®Google Scholar
• Stewart ZA, Locke JE, Montgomery RA, et al. ABO-incompatible deceased donor liver transplantation in the United States: a national Registry Analysis. Liver Transpl 2009;15(8):883–893. doi:10.1002/lt.21723.
   PubMed Web of Science ®Google Scholar
• Rana A, Kueht ML, Nicholas SK, et al. Pediatric liver transplantation across the ABO blood group barrier: is it an Obstacle in the Modern Era? J Am Coll Surg 2016;222(4):681–689. doi:10.1016/j.jamcollsurg.2015.12.041.
   PubMed Web of Science ®Google Scholar
• Mysore RK, Himes WH, Rana A, et al. ABO-incompatible deceased donor pediatric liver transplantation: novel titer-based management protocol and outcomes. Pediatr Transplant 2018;22(7):1–8.
   Web of Science ®Google Scholar
• Van Rijn R, Van Leeuwen OB, Matton APM, et al. Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers. Liver Transpl 2018;24(5):655–664. doi:10.1002/lt.25023.
   PubMed Web of Science ®Google Scholar
• Weeder PD, Va Rijn R, Porte RJ. Machine perfusion in liver transplantation as a tool to prevent non-anastomotic biliary strictures: rationale, current evidence and future directions. J Hepatol 2015;63(1):265–275. doi:10.1016/j.jhep.2015.03.008.
   PubMed Web of Science ®Google Scholar
• Bang JB, Kim B-W, Kim YB, et al. Risk factor for ischemic-type biliary lesion after ABO-incompatible living donor liver transplantation. World J Gastroenterol 2016; 22(30):6925–6935. doi:10.3748/wjg.v22.i30.6925.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev 2013;27(1):1–8. doi:10.1016/j.trre.2012.07.003.
   Web of Science ®Google Scholar
• Choi SH, Kim KW, Kim SY, et al. Computed tomography findings in ABO-incompatible living donor liver transplantation recipients with biliary strictures. Eur Radiol 2018;28(6):2572–2581.
   PubMed Web of Science ®Google Scholar